Resource: A focus on metastatic breast cancer, screening, survivorship
The purpose of this resource page is to provide a collection of relevant material that forms part of the Pink Ribbon/RSM breast cancer forum.
This material will help identify the best strategies for breast cancer prevention and cure, allowing practitioners from all parts of the breast cancer prevention and patient management cycle to identify major themes in the key issues of:
- Metastatic breast cancer –looking at oncological and radiotherapy treatments, including CDK 4/6 inhibitors and cyber knife; specialist nurse provision; models for drugs production and access.
- Screening – the current screening programme, duty of candour, imaging and ultrasound.
- “Living with and beyond” – key discussions based on complementary diet and exercise, progression free survival with psycho-oncology, and additional nascent psychological strategies.
- Additional presentations covering the political, personal and spiritual backgrounds to current initiatives to overcome breast cancer from Siobhan McDonagh MP, the breast cancer all-party parliamentary group (APPG) and US patient representative, Rev. Linda Loving.
Also available are key references for further reading and CPD accreditation.
lectures
Dr Rosalind Given-Wilson, Consultant Radiologist, St Georges University Hospitals NHS Foundation Trust
Date: 15th September 2017
Ms Siobhain McDonagh MP, APPG member.
Date: 15th September 2017
Dr Bhawna Sirohi, Consultant Medical Oncologist, Barts Cancer Institute
Date: 15th September 2017
Reverend Linda Loving, Author.
Date: 15th September 2017
Dr John Conibear, Consultant Clinical Oncologist, St Bartholomews’ Hospital.
Date: 15th September 2017
Dr Susannah Stanway, Consultant in Medical Oncology, Royal Marsden NHS Foundation Trust and Ms Vanda Ribeiro, Specialist Breast Cancer Nurse
Date: 15th September 2017
Professor Robert Thomas, Consultant Oncologist, Bedford and Addenbrooke’s Cambridge university hospitals NHS Trust
Date: 15th September 2017
Dr Joel Vos, Clinical and Health Psychologist and Philosopher (NL); Associate Professor in Counselling Psychology, University of Roehampton
Date: 15th September 2017
Professor Dame Lesley Fallowfield, DBE, Professor of Psycho-oncology, Brighton and Sussex Medical School, University of Sussex
Date: 15th September 2017
Dr Elena Pizzo, University College London
Date: 15th September 2017interviews and other videos
Various speakers from the Breast Cancer Forum.
Date: 14th November 2017Key references
All the references listed below are available in the RSM Library collection and can be accessed via the RSM’s e-resources area.
Liedtke, C. and Kolberg, H (2016) Systematic therapy of advanced/metastatic breast cancer – current evidence and future concepts. Breast care (Basel Switzerland), 11(4), pp. 275 – 281.
Zeichner, S.B., Terawaki, H. and Gogineni, K. (2016) A review of systemic treatment in metastatic triple-negative breast cancer. Breast cancer: basic and clinical research, 10, pp. 25-36.
Di Lascio, S. and Pagani, O. (2017). Is it time to address survivorship in advanced breast cancer? A review article. Breast (Edinburgh, Scotland), 31, pp. 167-172.
Fallowfield, L. and Jenkins, V., 2014. Psychosocial/survivorship issues in breast cancer: are we doing better? Journal of the National Cancer Institute, 107(1), pp. 335.
Given-Wilson, R. (2017) Commentary on duty of candour and cancer screening. The British Journal of Radiology, pp. 20170457.
Jorgensen, K.J, Kalager, M., Barratt, A., Baines, C., Zahl, P., Brodersen, J. and Harris, R.P. (2017) Overview of guidelines on breast screening: Why recommendations differ and what to do about it. Breast (Edinburgh, Scotland), 31, pp. 261-269.
Thomas, R.J., Kenfield, S.A and Jimenez, A (2017) Exercise-induced biochemical changes and their potential influence on cancer: a scientific review. British Journal of Sports Medicine 51(8), pp 640 – 644.
Hernandez-Blanquisett, A., Touya, D., Strasser-Weippl, K., Ruiz, R., St Louis, J. and Goss, P. (2016) Current and emerging therapies of HER2-positive metastatic breast cancer. Breast (Edinburgh, Scotland), 29, pp. 170 -7
External References
The following references are not available in the RSM Library; however they can be accessed online via external websites.
Beith, J., Burslem, K., Bell, R., Woodward, N., McCarthy, N., De Boer, R., Loi, S., and Redfern, A. (2016) Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape. Asia-Pacific Journal of Clinical Oncology, 12 Suppl 1, pp. 3-18. Online with PubMed Central at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807882
Massat, N.J., Sasieni, P.D., Tataru, D., Parmar, D., Cuzick, J. and Duffy, S.W., 2016. Explaining the better prognosis of screening-exposed breast cancers: Influence of tumor characteristics and treatment. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, co-sponsored by the American Society of Preventive Oncology, 25(3), pp. 479-87. Available with AACR Publications at: http://cebp.aacrjournals.org/content/25/3/479.long